Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Therapeutic siRNA: state of the art
2020
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
1998
Parenteral Anticoagulants
2008
Systemic Targeting of CpG-ODN to the Tumor Microenvironment with Anti–neu-CpG Hybrid Molecule and T Regulatory Cell Depletion Induces Memory Responses in BALB-neuT Tolerant Mice
2008 StandoutNobel
Effect of Sedation With Dexmedetomidine vs Lorazepam on Acute Brain Dysfunction in Mechanically Ventilated Patients
2007 Standout
Parenteral Anticoagulants
2012 Standout
Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients<subtitle>A Randomized Trial</subtitle>
2009 Standout
Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats
2001
Anticoagulant Use in Patients with Chronic Renal Impairment
2005
Selexipag for the Treatment of Pulmonary Arterial Hypertension
2015
Skeletal Muscle Fatigue: Cellular Mechanisms
2008 Standout
NEW AGENTS FOR SEDATION IN THE INTENSIVE CARE UNIT
2001
A Randomized Trial of Prenatal versus Postnatal Repair of Myelomeningocele
2011 Standout
Hexarelin, a potent GHRP analogue: Interactions with GHRH and clonidine in young and aged dogs
1995
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Contribution of platelets to tumour metastasis
2011 Standout
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
2002 StandoutNature
Cushing's syndrome
2015 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Neuroendocrinology of Prolonged Critical Illness: Effects of Exogenous Thyrotropin-Releasing Hormone and Its Combination with Growth Hormone Secretagogues1
1998
Growth of 9.5‐day rat embryos in folic‐acid‐deficient serum
1989
Drug-Induced Hepatotoxicity
2003 Standout
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
Systemic sclerosis
2017 Standout
Maternal Fever, Multivitamin Use, and Selected Birth Defects: Evidence of Interaction?
2002
The effect of an opiate antagonist on the hormonal changes induced by hexarelin
1995
Control of Immune Responses by Antigen-Specific Regulatory T Cells Expressing the Folate Receptor
2007 StandoutNobel
Population modelling of the effect of inogatran, at thrombin inhibitor, on ex vivo coagulation time (APTT) in healthy subjects and patients with coronary artery disease
2001
Antithrombotic Therapy for VTE Disease
2012 Standout
Cleft lip and palate
2009 Standout
Free radicals and muscle fatigue: Of ROS, canaries, and the IOC
2007
The Somatotropic Axis in Critical Illness: Effect of Continuous Growth Hormone (GH)-Releasing Hormone and GH-Releasing Peptide-2 Infusion1
1997
Mast cell tryptases and chymases in inflammation and host defense
2007
Meningomyelocele: Managementin uteroand Post Natum
2007
Maternal and child undernutrition: global and regional exposures and health consequences
2008 Standout
The development of allergic inflammation
2008 StandoutNature
Exogenous growth hormone administration does not inhibit the growth hormone response to hexarelin in normal men
1995
Heparin-Induced Thrombocytopenia
2006 Standout
Mast Cell Proteases
2007
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses
2004 Standout
Prevention of Venous Thromboembolism
2004 Standout
Identification of two putative novel folate receptor genes in humans and mouse
2000
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Antisense oligonucleotides as therapeutic agents
1999
The incidence of congenital heart disease
2002 Standout
Normal Functional Capacity in Circulating Myeloid and Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C
2005 StandoutNobel
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Development of a Novel Recombinant Serpin with Potential Antithrombotic Properties
1995
Fondaparinux Sodium Mechanism of Action
2002
Revealing the world of RNA interference
2004 StandoutNatureNobel
Effects of N‐acetylcysteine on glutathione oxidation and fatigue during handgrip exercise
2005
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease
2002
Antisense Pharmacodynamics: Critical Issues in the Transport and Delivery of Antisense Oligonucleotides
1999
Folate and human reproduction
2006
N-acetylcysteine inhibits muscle fatigue in humans.
1994
Paracetamol (acetaminophen) poisoning
1993
Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: Observations from the TIMI 8 trial
2002
Ghrelin: Structure and Function
2005 Standout
Birth defects in Arkansas: Is folic acid fortification making a difference?
2004
Hexarelin induced growth hormone release is influenced by exogenous growth hormone
1995
De testimonio: on the evidence for decisions about the use of therapeutic interventions
2008
Pathogen Recognition and Innate Immunity
2006 Standout
Adrenocorticotropin- and Cortisol-Releasing Effect of Hexarelin, a Synthetic Growth Hormone-Releasing Peptide, in Normal Subjects and Patients with Cushing’s Syndrome1
1997
The drug methoxsalen, a suicide substrate for cytochrome P-450, decreases the metabolic activation, and prevents the hepatotoxicity, of carbon tetrachloride in mice
1987
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
N-acetylcysteine infusion alters blood redox status but not time to fatigue during intense exercise in humans
2003
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
2004
Hirulog in the Treatment of Unstable Angina
1995
Serpin Structure, Mechanism, and Function
2002 Standout
Absence of Placental Transfer of Pentasaccharide (Fondaparinux, Arixtra®) in the Dually Perfused Human Cotyledon in vitro
2002
Air Pollution and Cardiovascular Disease
2004 Standout
The Growth Hormone Secretagogue Hexarelin Stimulates the Hypothalamo-Pituitary-Adrenal Axis via Arginine Vasopressin
1999
Beta-blocker and calcium channel blocker toxicity.
1994
Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
1994
Progress in the Delivery of Therapeutic Oligonucleotides: Organ/Cellular Distribution and Targeted Delivery of OligonucleotidesIn Vivo
2003
British Guideline on the Management of Asthma
2008
β-Blocker and Calcium Channel Blocker Toxicity
1994
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
Insertion of an intracisternal A particle within the 5'-regulatory region of a gene encoding folate-binding protein in L1210 leukemia cells in response to low folate selection. Association with increased protein expression.
1992 StandoutNobel
Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study.
1996
Interpreting the International Normalized Ratio (INR) in Individuals Receiving Argatroban and Warfarin
2001
Dexmedetomidine: An Updated Review
2007
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
2003 Standout
Managing anticoagulant and antiplatelet drugs in patients who are receiving neuraxial anesthesia and epidural analgesia: a practical guide for clinicians
2006
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis
2004
Phase I Clinical and Pharmacokinetic Study of Bcl-2 Antisense Oligonucleotide Therapy in Patients With Non-Hodgkin’s Lymphoma
2000
A possible increase in the incidence of congenital heart defects among the offspring of affected parents
1985
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time
2010 StandoutNobel
Peptidomimetic Regulation of Growth Hormone Secretion
1997
Part 14: Pediatric Advanced Life Support
2010 Standout
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
1999 StandoutNature
Hepatotoxicity from paracetamol self‐poisoning in western Sydney: a continuing challenge
1992
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Protease-Activated Receptors: Contribution to Physiology and Disease
2004
Review: Genetics of systemic lupus erythematosus
1995
Physiology of Microglia
2011 Standout
Works of Tim Mant being referenced
Adverse reactions to acetylcysteine and effects of overdose.
1984
Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction
2002
Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions
1999
Growth hormone-releasing activity of hexarelin in humans
1994
THE LACK OF RELATIONSHIP BETWEEN ACETYLATOR PHENOTYPE AND IDIOPATHIC SYSTEMIC LUPUS ERYTHEMATOSUS IN A SOUTH-EAST ASIAN POPULATION: A STUDY OF INDIANS, MALAYS AND MALAYSIAN CHINESE
1990
Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma
2001
Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag
2015
A Subcutaneously Administered Investigational RNAi Therapeutic, Fitusiran (ALN-AT3), Targeting Antithrombin for Treatment of Hemophilia: Interim Results in Patients with Hemophilia A or B
2016
Anticoagulant Activity of Hirulog™, a Direct Thrombin Inhibitor, in Humans
1993
Phase I Safety and Pharmacokinetic Profile of an Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide (ISIS 2302)
1997
ACUTE CARBON TETRACHLORIDE POISONING IN 19 PATIENTS: IMPLICATIONS FOR DIAGNOSIS AND TREATMENT
1985
Pharmacokinetics and Tolerance of the Natural Pentasaccharide (SR90107/ORG31540) with High Affinity to Antithrombin III in Man
1995
Recovery after Severe Oxprenolol Overdose Complicated by Rhabdomyolysis
1985